CARL Carlsmed, Inc.

NASDAQ
$14.32

Carlsmed, Inc. (CARL) is expected to report earnings on November 4, 2026, after the market close. The consensus earnings estimate is a loss of $0.41 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +3.0% since its last earnings release on August 5, 2026.

Carlsmed Beat Consensus Estimates, Raises Guidance, but Remains In-line with Estimates
Wednesday, August 5, 2026 · 4:01 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 4
Wednesday · 4:00 PM ET
Earnings Whisper
-
vs ($0.41)
Rev est $19.01M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $13.80

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Carlsmed, Inc.

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Held By 1 ETFs, by dollar flow